In the current study, KEGG pathway enrichment analyses have revealed changes related to primary immunodeficiency in severe MPP patients, which involves CD79A, AICDA, CD19, and TNFRSF13C genes (Table 4, Fig. 3) [22]. This evidence concerns the gene AICDA and inborn error of immunity.